The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins

被引:6
作者
Beljaars, L
Floris, R
Berkhout, B
Smit, C
Meijer, DKF
Molema, G
机构
[1] Univ Groningen, Inst Drug Explorat, GUIDE, Dept Pharmacokinet & Drug Delivery,Ctr Pharm, NL-9713 AV Groningen, Netherlands
[2] NIZO Food Res, Dept Prod Technol, Ede, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Groningen, Inst Drug Explorat, GUIDE,Dept Pathol & Lab Med, Tumor Immunol Lab,Med Biol Sect, NL-9713 AV Groningen, Netherlands
关键词
HIV; polyanions; Suc-HSA; structure; heparin; entry inhibitor;
D O I
10.1016/S0006-2952(02)00912-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The substitution of human serum albumin with negatively charged molecules, such as succinic acid (Suc-HSA) or aconitic acid (Aco-HSA), resulted in proteins with potent anti-HIV activities, by binding to viral gp120 (V3 loop). The aim of the present study was to investigate whether the distribution of negative charges on the albumin backbone influences the anti-HIV activity. Therefore, we prepared albumins with clusters of negatively charged groups by coupling of heparin. The effects of this substitution on anti-HIV activity, in vivo distribution and the protein structure as compared to random succinylation were assessed. In vitro studies indicated that HSA-modified with heparin 6 or 13 kD displayed anti-HIV activity (IC50 = 660 and 37 nM, respectively) and exhibited affinity for gp120-V3 loop, although the activity was lower than that of Suc-HSA. Combined derivatization of HSA with heparin 13 kD and aconitic acid groups resulted in significantly increased inhibitory actions (IC50 = 2.8 nM). Structural analysis showed that modification of HSA with heparin did not lead to extensive unfolding of the protein, meaning that these modified proteins were still globular in structure. In contrast, succinylation of HSA resulted in a highly randomly coiled conformation. Dynamic light scattering experiments revealed that, at neutral pH, the heparin fragments attached to the protein were wrapped around the molecule rather than sticking out into the solution. In conclusion, coupling of sufficient clustered negative charges, by coupling of Hep-fragments, on HSA resulted in a clear anti-HIV activity of the protein. Yet, random distribution of anionic groups in the albumin seemed more optimal for in vitro anti-HIV activity. The higher plasma and lymphatic concentrations of Hep-HSA compared to Suc-HSA seemed more favorable for an anti-HIV activity in vivo. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1663 / 1673
页数:11
相关论文
共 32 条
  • [1] Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme
    Back, NKT
    Nijhuis, M
    Keulen, W
    Boucher, CAB
    Essink, BBO
    vanKuilenburg, ABP
    vanGennip, AH
    Berkhout, B
    [J]. EMBO JOURNAL, 1996, 15 (15) : 4040 - 4049
  • [2] Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor
    Beljaars, L
    Molema, G
    Schuppan, D
    Geerts, A
    De Bleser, PJ
    Weert, B
    Meijer, DKF
    Poelstra, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) : 12743 - 12751
  • [3] Structural and functional analysis of negatively charged milk proteins with anti-HIV activity
    Berkhout, B
    Derksen, GCH
    Back, NKT
    Klaver, B
    deKruif, CG
    Visser, S
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (13) : 1101 - 1107
  • [4] HIV-1 entry - an expanding portal for drug discovery
    Blair, WS
    Lin, PF
    Meanwell, NA
    Wallace, OB
    [J]. DRUG DISCOVERY TODAY, 2000, 5 (05) : 183 - 194
  • [5] CHROMATOFOCUSING OF SIALOGLYCOPROTEINS
    BURNESS, ATH
    PARDOE, IU
    [J]. JOURNAL OF CHROMATOGRAPHY, 1983, 259 (03): : 423 - 432
  • [6] Current evidence and future directions for targeting HIV entry - Therapeutic and prophylactic strategies
    D'Souza, MP
    Cairns, JS
    Plaeger, SF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (02): : 215 - 222
  • [7] PHARMACOKINETICS, TOXICITY, AND ACTIVITY OF INTRAVENOUS DEXTRAN SULFATE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    FLEXNER, C
    BARDITCHCROVO, PA
    KORNHAUSER, DM
    FARZADEGAN, H
    NERHOOD, LJ
    CHAISSON, RE
    BELL, KM
    LORENTSEN, KJ
    HENDRIX, CW
    PETTY, BG
    LIETMAN, PS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) : 2544 - 2550
  • [8] FORD WL, 1980, HDB EXPT IMMUNOLOGY
  • [9] PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY
    GREENWOOD, FC
    HUNTER, WM
    [J]. BIOCHEMICAL JOURNAL, 1963, 89 (01) : 114 - &
  • [10] Population biology of HIV-1 infection:: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues
    Haase, AT
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 625 - 656